In this episode of 340Banter, we sit down with Christina Harbison, Senior Clinical Pharmacist at Prism Health North Texas, to discuss how the organization grew its long-acting injectable (LAI) program from 18 patients to approximately 700.

Christina shares how Prism Health North Texas has navigated medication acquisition, prescription and medical benefits, buy-and-bill, prior authorizations, and payer requirements while expanding access to long-acting injectable options for HIV treatment and prevention.

We also discuss the operational aspects of building an LAI program, including securing organizational buy-in, developing the right staffing model, verifying coverage prior to administration, and involving pharmacists in medication management and patient counseling.

For health centers considering long-acting injectables or working to expand an existing program, Christina offers practical advice based on Prism Health North Texas' experience: start slowly, understand the financial risks, establish reliable processes, and ensure patients can maintain access to treatment over time.

Let’s connect:

https://www.fqhc340b.com/

[email protected]

(760) 780-7469